Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study

Published:2024-08 Issue: Volume:76 Page:103740
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Duan Fangfang,Hua Xin,Bi Xiwen,Wang Shusen,Shi Yanxia,Xu Fei,Wang Li,Huang Jiajia,Yuan Zhongyu,Huang Yuanyuan

Funder

National Natural Science Foundation of China

Guangzhou Municipal Science and Technology Project

Natural Science Foundation of Guangdong Province

Publisher

Elsevier BV

Reference25 articles.

1. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

2. Dissecting the heterogeneity of triple-negative breast cancer;Metzger-Filho;J Clin Oncol,2012

3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat Rev Clin Oncol,2016

4. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies;Denkert;Lancet,2017

5. Triple-negative breast cancer: therapeutic options;Cleator;Lancet Oncol,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP